Building an Investible
IP Portfolio in
Biotech and Pharma
Build an IP Strategy that attracts investors and maximises value.
Download the UPC Review
By accessing, you agree to our Privacy Policy and are subscribed
to our mailing list. Unsubscribe at any time.
to our mailing list. Unsubscribe at any time.
About this edition
Building an investible IP portfolio — the essential roadmap to maximise your IP value.
For biotech and pharmaceutical companies, intellectual property is often the single most valuable business asset. A well-designed IP strategy can increase company valuation, strengthen fundraising efforts, support licensing discussions, and improve acquisition prospects.
In this practical guide, EIP's Stratiphy® team explores how life sciences innovators can build an investible IP portfolio that balances scientific progress, commercial objectives, and investor expectations. Whether you're preparing for seed funding, scaling towards clinical trials, or positioning for acquisition, this whitepaper provides actionable insights on developing an IP strategy that supports long-term growth and commercial success.
Download Building an Investible IP Portfolio in Biotech and Pharma to start building a more investible portfolio today.
In this practical guide, EIP's Stratiphy® team explores how life sciences innovators can build an investible IP portfolio that balances scientific progress, commercial objectives, and investor expectations. Whether you're preparing for seed funding, scaling towards clinical trials, or positioning for acquisition, this whitepaper provides actionable insights on developing an IP strategy that supports long-term growth and commercial success.
Download Building an Investible IP Portfolio in Biotech and Pharma to start building a more investible portfolio today.
What you'll learn:
Develop a cost-effective patent strategy
Learn how to prioritise patent protection, align IP decisions with business goals, and manage costs without compromising value.
Get patent filing timing right
Discover the factors that influence filing strategy and why timing can significantly impact investment attractiveness and future patent value.
Protect the right assets in the right markets
Understand what to protect, where to file, and how to build a patent portfolio that supports commercial objectives
Manage freedom-to-Operate risks
Explore best practices for identifying and addressing third-party patent risks throughout the R&D and commercialisation lifecycle.
Structure collaborations for growth
Learn how partnership agreements, licensing arrangements, and joint development projects can affect company valuation and investment readiness.
Maximise patent term extensions
Understand how Supplementary Protection Certificates (SPCs) and patent term extensions can add valuable years of protection to pharmaceutical innovations.
Learn how to prioritise patent protection, align IP decisions with business goals, and manage costs without compromising value.
Get patent filing timing right
Discover the factors that influence filing strategy and why timing can significantly impact investment attractiveness and future patent value.
Protect the right assets in the right markets
Understand what to protect, where to file, and how to build a patent portfolio that supports commercial objectives
Manage freedom-to-Operate risks
Explore best practices for identifying and addressing third-party patent risks throughout the R&D and commercialisation lifecycle.
Structure collaborations for growth
Learn how partnership agreements, licensing arrangements, and joint development projects can affect company valuation and investment readiness.
Maximise patent term extensions
Understand how Supplementary Protection Certificates (SPCs) and patent term extensions can add valuable years of protection to pharmaceutical innovations.